Related references
Note: Only part of the references are listed.Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021
Christina C. Chang et al.
INTERNAL MEDICINE JOURNAL (2021)
Treatment of invasive IMP-4 Enterobacter cloacae infection in transplant recipients using ceftazidime/avibactam with aztreonam: A case series and literature review
Kelly A. Cairns et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practices
Sahand Imani et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Auditing fungal disease in leukemia patients in a tertiary care center: opportunities and challenges for an antifungal stewardship program
Emma Paige et al.
LEUKEMIA & LYMPHOMA (2019)
The increasing importance of community-acquired methicillin-resistant Staphylococcus aureus infections
Jason W. Agostino et al.
MEDICAL JOURNAL OF AUSTRALIA (2017)
A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013
Ian Nivison-Smith et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Antibiotic resistance: are we all doomed?
P. Collignon
INTERNAL MEDICINE JOURNAL (2015)
2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci - from disaster to ongoing control
J. W. Pearman
JOURNAL OF HOSPITAL INFECTION (2006)
Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection
LA Garske et al.
JOURNAL OF HOSPITAL INFECTION (2004)